LUCAR-G79
/ Legend Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 03, 2026
A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)
(clinicaltrials.gov)
- P1 | N=38 | Recruiting | Sponsor: Nanjing Legend Biotech Co. | Not yet recruiting ➔ Recruiting
Enrollment open • Immunology • Inflammatory Arthritis • Lupus • Myositis • Systemic Lupus Erythematosus
January 10, 2026
A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)
(clinicaltrials.gov)
- P1 | N=38 | Not yet recruiting | Sponsor: Nanjing Legend Biotech Co.
New P1 trial • Immunology • Inflammatory Arthritis • Lupus • Myositis • Systemic Lupus Erythematosus
1 to 2
Of
2
Go to page
1